Celiac Disease: Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 15, 2022
April 18, 2022
4fbd41e3-3158-4644-a1f3-69e97587f939
Related Documents
Migraine: Developing Drugs for Preventive Treatment
Guidance DocumentJune 1, 2023Center for Drug Evaluation and Research
Endogenous Cushing’s Syndrome: Developing Drugs for Treatment
Guidance DocumentSeptember 8, 2023Center for Drug Evaluation and Research
Crohn’s Disease: Developing Drugs for Treatment
Guidance DocumentApril 28, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox